维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Scordo"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhibition of risperidone metabolism by flouxetine in patients with schizophrenia:a clinically relevant pharmacokinetic drug interaction显示文摘	SPINA E AVENOSO A SCORDO M G		0，，04：	1
2	Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance显示文摘	SCORDO M G PENGO V SPINA E	2002	Chin Pharmacol Ther2002，72，6：	1
3	Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction显示文摘	Spina E Avenoso A Scordo M G	2002	J Clin Psychopharmacol2002，22，4：	1
4	Cytochrome P-450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxy risperidone 显示文摘	SCORDO MG SPINA E FACCIOLA G	1999	Psychopharmacology1999，147，2：	1
5	No effect of the new antidepressant reboxetine on CYP2D6activity in healthy volunteers显示文摘	Facciola G Scordo MG Spina E	1999	Ther Drug Monit1999，21，5：	1
6	Action of caffeine, L-PIA and their combination on memory retention in the rat显示文摘	Molinengo L Scordo I Pastorello B	1994	Life Sci1994，54，17：	1
7	Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine显示文摘	Gunes A Melkersson KI Scordo MG	2009	J Clin Psychcpharmacol2009，29，1：	1
8	Metabolic drug interaction with new psychotropic agent显示文摘	Spina E Scordo MG D’Arrigo C	2003	Fund&Clin Pharmacol2003，17，：	1
9	Allele and genotype frequencies of CYP2C9 , CYP2C19 and CYP2D6 in an Italian population显示文摘	Maria Gabriella Scordo Achille P Caputi Concetta D’Arrigo Giuseppina Fava Edoardo Spina	2004	Pharmacological Research2004，，2：	1
10	Inhibition of Risperidone Metabolism by Fluoxetine in Patients With Schizophrenia:A Clinically Relevant Pharmacokinetic Drug Interaction显示文摘	Spina E Avenoso A Scordo MG Ancione M Madia A Gatti G	2002	J Clin Psychopharmacol2002，22，：	1
11	Adverse drug interaction between risperidone and carbamaz- epine in a patient with chronic schizophrenia and de- ficient CYP2D6 activity显示文摘	Spina E Scordo MG Avenoso A	2001	J Clin Psychopharma- col2001，21，1：	1
12	Metabolic drug interaction with new psychotropic agent 显示文摘	Spina E Scordo MG D' Arrido C	2003	Fundam Clin Pharmacol2003，17，：	1
13	Genetic polymorphisan of cy- tochrome P450 2C9 in a Caucasian and a Black African population显示文摘	Scordo MG Aklillu E Yasar U	2001	Br J Clin Pharmacol2001，52，4：	1
14	Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabo- lism and on insulin and lipid elevations and insulin re- sistance in clozapine -treated patient显示文摘	Melkersson K I Scordo M G Gunes A	2007	J Clin Psychi- atry2007，68，5：	1
15	Cytochrome P450 polymorphisms and response to antipsychotic therapy显示文摘	Scordo MG Spina E	2002	Pharmacogenomics2002，3，2：	1
16	Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population显示文摘	Scordo MG Caputi AP D'ARRIGO Concetta	2004	Pharmacol Res2004，50，2：	1
17	Clinically significant drug interactions with an-tidepressants in the elderly 显示文摘	Spina E Scordo M G	2002	Drugs Aging2002，19，4：	1
18	Pretransplantation fluorine- 18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-Hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation 显示文摘	Sauter CS Lechner L Scordo M	2014	Biol Blood Marrow Transplant2014，20，6：	1
19	A polipoprotein E (APOE) and w arfarin dosing in an Ita lia n popula tio n 显示文摘	Kohnke H Scordo M G Pengo Y et a l	2005	Eur J Clin Pharmacol2005，61，10：	1
20	Metabolic drug interactions with new psychotropic agents显示文摘	Spina E Scordo MG DArrigo C	2003	Fundam Clin Pharmacol2003，17，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示